China Nanjing Bio-medical Valley2013-11-18 03:46:28
located at the foot of the Longwang Hill within the Hi-tech Industrial Development Zone, it is designed to cover a total area of 10 square kilometers, with 3 square kilometers for R&D and 7 suqare kilometers for industrial development.
It has so far attracted 105 bio-medical companies mainly engaged in drug production, medical instruments, clinical preparations, service outsourcing, cold-chain logistics, high-end R&D and new drug invention sectors. It has a number of research-supporting platforms such as the National Resource Center for Mutant Mice, the National Engineering Center for Standardization of Chinese Medicine Processing and the national-level Dingye-BTCR Bio-medical Technology Incubator, and has established a public technological service platform for medical R&D. Next, it will set up the National Clinical Test Center and the National Clinical Database.
Since 2011, it will annually build 400,000 square meters of new carriers, incubators and accelerators for innovation-oriented R&D activities, and will start to set up the public service platform for Nanjing Bio-medical Valley. By 2015, it will have a total of 1,000 enterprises under incubation and will have 200 production corporations introduced and 12 specialized R&D technological centers established. Its key construction projects include: Nanjing Bio-medical Public Instrumental Service Platform, NU Model Animal Research Institute, the International Service Center for Toxicology and New Drug Safety Evaluation, the R&D and Engineering Center for the Quality Standard on Chinese Medicinal Decoction Pieces, Pre-clinical Pharmacology and Effect Research Center, the R&D Center for the Medical Instruments of Minimally-invasive Surgery, Translational Medicine Center, the R&D Center for Regenerative Medicine, Antibody Center, and the Practice Base for Entrepreneurship, Innovation and Creation.